Cardlytics
CDLX
144 hedge funds and large institutions have $516M invested in Cardlytics in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 19 closing their positions.
105% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 19
85% more capital invested
Capital invested by funds: $279M → $516M (+$236M)
58% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 33
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
16% more funds holding
Funds holding: 124 → 144 (+20)
0.35% more ownership
Funds ownership: 7.73% → 8.08% (+0.35%)
23% less call options, than puts
Call options by funds: $17.2M | Put options by funds: $22.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
CAS Investment Partners
Westport,
Connecticut
|
+$8.09M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$4.66M |
| 3 |
6CM
683 Capital Management
New York
|
+$3.9M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.78M |
| 5 |
TGM
Tenzing Global Management
San Francisco,
California
|
+$3.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brightlight Capital Management
Westport,
Connecticut
|
-$2.53M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.7M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.66M |
| 4 |
Goldman Sachs
New York
|
-$1.28M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.2M |
CDLX Hedge Fund Activity: Q1 2024 in Review
144 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2024, worth a combined $516M — up 85% from $279M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new CDLX positions and 19 closed out — a net gain of 20 holders — while 52 added to existing stakes and 33 trimmed.
The largest buyer was CAS Investment Partners, adding an estimated $8.09M. The largest seller was Brightlight Capital Management, cutting an estimated $2.53M.
- 144 institutional investors held Cardlytics (CDLX) as of Q1 2024, up from 124 in Q4 2023.
- Funds reported $516M of Cardlytics stock for Q1 2024, up 85% quarter-over-quarter.
- 39 funds opened new Cardlytics positions in Q1 2024 and 19 closed out, a net change of +20 holders.
- The largest Cardlytics buyer in Q1 2024 was CAS Investment Partners, an estimated $8.09M added.
- The largest Cardlytics seller in Q1 2024 was Brightlight Capital Management, an estimated $2.53M sold.
Based on aggregated 13F filings for Q1 2024.